Aberrant DNA methylation status in human uterine leiomyoma

Molecular Human Reproduction

Volumn 15, Issue 4, 2009, Pages 259-267

  Yamagata, Yoshiaki ^a   Maekawa, Ryo ^a   Asada, Hiromi ^a   Taketani, Toshiaki ^a   Tamura, Isao ^a   Tamura, Hiroshi ^a   Ogane, Jun ^b   Hattori, Naka ^c   Shiota, Kunio ^b   Sugino, Norihiro ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c AJINOMOTO CO INC   (Japan)

Author keywords

DNA methylation; Leiomyoma; RLGS

Indexed keywords

DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; MESSENGER RNA;

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RESTRICTION LANDMARK GENOMIC SCANNING; TISSUE DISTRIBUTION; UTERUS MYOMA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DNA METHYLATION; DNA MODIFICATION METHYLASES; EXONS; FEMALE; GENOME, HUMAN; HUMANS; LEIOMYOMA; MIDDLE AGED; MYOMETRIUM; UTERINE NEOPLASMS;

EID: 63149140121     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gap010     Document Type: Article

References (35)

1. Ahn WS, Kim KW, Bae SM, Yoon JH, Lee JM, Namkoong SE, Kim JH, Kim CK, Lee YJ, Kim YW. Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis. Int J Exp Pathol 2003;84:267-279.
2. Asada H, Yamagata Y, Taketani T, Matsuoka A, Tamura H, Hattori N, Ohgane J, Hattori N, Shiota K, Sugino N. Potential link between estrogen receptor-α gene hypomethylation and uterine fibroid formation. Mol Hum Reprod 2008;14:539-545.
3. Ballestar E, Esteller M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 2002; 23:1103-1109.
4. Catherino WH, Leppert PC, Stenmark MH, Payson M, Potlog-Nahari C, Nieman LK, Segars JH. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer 2004;40:204-217.
5. Chiaffarino F, Parazzini F, La Vecchia C, Chatenoud L, Di Cintio E, Marsico S. Diet and uterine myomas. Obstet Gynecol 1999;94 395-398.
6. Cho J-H, Kimura H, Minami T, Ohgane J, Hattori N, Tanaka S, Shiota K. DNA methylation regulates placental lactogen I gene expression. Endocrinology 2001;142:3389-3396.
7. El-Osta A. The rise and fall of genomic methylation in cancer. Leukemia 2004;18:233-237.
8. Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 2001a; 153: 1-10.
9. Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 2001b; 153:11-19.
10. Feinberg AP, Cu,i H, Ohlsson R. DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin Cancer Biol 2002;12:389-398.
11. Girault I, Tozlu S, Lidereau R, Bieche I. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 2003;9:4415-4422.
12. Hattori N, Abe T, Hattori N, Suzuki M, Matsuyama T, Yoshida S, Li E, Shiota K. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells. Genome Res 2004a;14:1733-1740.
13. Hattori N, Nishino K, Ko YG, Hattori N, Ohgane J, Tanaka S, Shiota K. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem 2004b;279 17063-17069.
14. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
15. Hsieh CL. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b. Mol Cell Biol 1999;19 8211-8218.
16. Ikegami K, Iwatani M, Suzuki M, Tachibana M, Shinkai Y, Tanaka S, Greally JM, Yagi S, Hattori N, Shiota K. Genome-wide and locus-specific DNA hypomethylation in G9a deficient mouse embryonic stem cells. Genes Cells 2007;12:1-11.
17. Imamura T, Ohgane J, Ito S, Ogawa T, Hattori N, Tanaka S, Shiota K. CpG island of rat sphingosine kinase-1 gene: Tissue-dependent DNA methylation status and multiple alternative first exons. Genomics 2001; 76:117-125.
18. Imir AG, Lin Z, Yin P, Deb S, Yilmaz B, Cetin M, Cetin A, Bulun SE. Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II. J Clin Endocrinol Metab 2007; 92: 1979-1982.
19. Kremenskoy M, Kremenska Y, Ohgane J, Hattori N, Tanaka S, Hashizume K, Shiota K. Genome-wide analysis of DNA methylation status of CpG islands in embryoid bodies, teratomas, and fetuses. Biochem Biophys Res Commun 2003;311:884-890.
20. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002;3:662-673.
21. Li S, Chiang TC, Richard-Davis G, Barrett JC, McLachlan JA. DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma. Gynecol Oncol 2003;90:123-130.
22. Liu Y, Okakeley EJ, Sun L, Jost JP. Multiple domains are involved in the targeting of the mouse DNA methyltransferase to the DNA replication foci. Nucleic Acids Res 1998;26:1038-1045.
23. Matsuyama T, Kimura MT, Koike K, Abe T, Nakano T, Asami T, Ebisuzaki T, Held WA, Yoshida S, Nagase H. Global methylation screening in the Arabidopsis thaliana and Mus musculus genome: Applications of virtual image restriction landmark genomic scanning (Vi-RLGS). Nucleic Acids Res 2003;31:4490-4496.
24. Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol 2005; 48:312-324.
25. Shiota K. DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet Genome Res 2004;105:325-334.
26. Shiota K, Yanagimachi R. Epigenetics by DNA methylation for development of normal and cloned animals. Differentiation 2002; 69 162-166.
27. Shiota K, Kogo Y, Ohgane J, Imamura T, Urano A, Nishino K, Tanaka S, Hattori N. Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 2002;7:961-969.
28. Shozu M, Sumitani H, Segawa T, Yang HJ, Murakami K, Kasai T, Inoue M. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J Clin Endocrinol Metab 2002;87:2540-2548.
29. Smith SS. Biological implications of the mechanism of action of human DNA (cytosine-5)methyltransferase. Prog Nucleic Acid Res Mol Biol 1994;49:65-111.
30. Ting AH, Jair KW, Suzuki H, Yen RW, Baylin SB, Schuebel KE. Mammalian DNA methyltransferase 1: Inspiration for new directions. Cell Cycle 2004;3:1024-1026.
31. Tsibris JC, Segars J, Coppola D, Mane S, Wilbanks GD, O'Brien WF, Spellacy WN. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 2002;78 114-121.
32. Ushijima T, Okochi-Tanaka E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci 2005;96:206-211.
33. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: A clinical review. Br J Obstet Gyneacol 1990;97:285-298.
34. Wang H, Mahadevappa M, Yamamoto K, Wen Y, Chen B, Warrington JA, Polan ML. Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril 2003;80 266-276.
35. Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ, Rogers PA. Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod 2003; 9 541-549.